Oncology & Cancer

Fitness trackers keep cancer survivors on the move

A new study shows that activity trackers such as pedometers and smartphone apps are linked to improved step counts and exercise engagement for cancer survivors. The devices have the appeal of being convenient, home-based, ...

Oncology & Cancer

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently published in JAMA Oncology.

page 27 from 40